“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
Woman, clinically dead for 42-minutes, brought back to life by Australian doctors
Americans fall out of favour with Swiss banks
UN calls on US to stop separating migrant children from parents
Hey Australia, How's That Gun Ban Working?
Apple says never worked with NSA on iPhone hacks
Mister Taxman: Why Some Americans Working Abroad are Ditching Their Citizenships
Privacy fears cause more to cover online tracks
How An African 'Princess' Banked $3 Billion In A Country Living On $2 A Day
Eric Holder ‘confident’ of bringing NSA whistleblower Edward Snowden ‘to justice’
India state moves to ban black magic after anti-superstition activist gunned down
Government 'Cyber Troops' Manipulate Facebook, Twitter: Oxford Study
Obama urged to fulfill Guantanamo closure pledge
Bank of America intern's death puts banks' working culture in spotlight
Smart Rifle never misses, now comes in semi-automatic form
Bitcoin’s Gains May Fuel Central Bank Concerns